Jeroan Allison to Gastrointestinal Diseases
This is a "connection" page, showing publications Jeroan Allison has written about Gastrointestinal Diseases.
Connection Strength
0.184
-
Fry RB, Ray MN, Cobaugh DJ, Weissman NW, Kiefe CI, Shewchuk RM, Saag KG, Curtis JR, Allison JJ. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior. Arthritis Rheum. 2007 Dec 15; 57(8):1539-45.
Score: 0.071
-
Patino FG, Olivieri J, Allison JJ, Mikuls TR, Moreland L, Kovac SH, Juarez L, Person S, Curtis J, Saag KG. Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices. J Rheumatol. 2003 Dec; 30(12):2680-8.
Score: 0.054
-
Chaiamnuay S, Allison JJ, Curtis JR. Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm. 2006 Oct 01; 63(19):1837-51.
Score: 0.016
-
Berner ES, Houston TK, Ray MN, Allison JJ, Heudebert GR, Chatham WW, Kennedy JI, Glandon GL, Norton PA, Crawford MA, Maisiak RS. Improving ambulatory prescribing safety with a handheld decision support system: a randomized controlled trial. J Am Med Inform Assoc. 2006 Mar-Apr; 13(2):171-9.
Score: 0.016
-
Saag KG, Olivieri JJ, Patino F, Mikuls TR, Allison JJ, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. Arthritis Rheum. 2004 Jun 15; 51(3):337-49.
Score: 0.014
-
Patino FG, Allison J, Olivieri J, Mudano A, Juarez L, Person S, Mikuls TR, Moreland L, Kovac SH, Saag KG. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum. 2003 Jun 15; 49(3):293-9.
Score: 0.013